+919426709766
Govt of India
An ISO 9001:2008
Alendronate Sodium

Alendronate Sodium

4000 INR/Kilograms

Product Details:

  • Medicine Name ALENDRONATE SODIUM TRIHYDRATE
  • Grade Industrial Grade
  • Physical Form Powder
  • Supply Ability : 500 Kilograms Per Day
  • Click to view more
X

Price And Quantity

  • 55 Kilograms
  • 4000 INR/Kilograms

Product Specifications

  • Industrial Grade
  • Powder
  • ALENDRONATE SODIUM TRIHYDRATE

Trade Information

  • 500 Kilograms Per Day
  • 1 Days

Product Description

NAME :- ALENDRONATE SODIUM

IUPAC NAME :- sodium [4-amino-1-hydroxy-1-(hydroxy-oxido-phosphoryl)- butyl]phosphonic acid trihydrate

CAS NO. :- 121268-17-5

FORMULA :- C4H13NO7P2

SYNONYMS :- G-704650;ALENDRONATE SODIUM SALT;ALENDRONATE, SODIUM SALT TRIHYDRATE;ALENDRONATE SODIUM TRIHYDRATE;ALENDRONNATE SODIUM TRIHYDRATE;ALENDRONIC ACID, MONOSODIUM SALT, TRIHYDRATE;ADRONAT;4-AMINO-1-HYDROXYBUTYLIDINE-1,1-BISPHOSPHONATE SODIUM SALT TRIHYDRATE

APPLICATION :- Inhibits bone resorption and increases bone density.

DESCRIPTION :- Alendronate chemical compound is a nitrogen-containing, second generation bisphosphonate. Bisphosphonates were first used to treat Paget s disease in 1971. This class of medications is comprised of inorganic pyrophosphate analogues that contain non-hydrolyzable P-C-P bonds. Similar to other bisphosphonates, alendronate has a high affinity for bone mineral and is taken up during osteoclast resorption. Alendronate inhibits farnesyl pyrophosphate synthetase, one of the enzymes in the mevalonic acid pathway involved in producing isoprenoid compounds that are essential for post-translational modification of small guanosine triphosphate (GTP)-binding proteins, such as Rho, Ras and Rab. Inhibition of this process interferes with osteoclast function and survival. Alendronate is used for the treatment of osteoporosis and Paget s disease.

Product details 

Application

Inhibits bone resorption and increases bone density.

Molecular Formula

C4H13NO7P2

IUPAC Name

Sodium [4-amino-1-hydroxy-1-(hydroxy-oxido-phosphoryl)- butyl]phosphonic acid trihydrate

CAS Number

121268-17-5

Application

Inhibits bone resorption and increases bone density.

Molecular Formula

C4H13NO7P2

IUPAC Name

Sodium [4-amino-1-hydroxy-1-(hydroxy-oxido-phosphoryl)- butyl]phosphonic acid trihydrate

CAS Number

121268-17-5

Enter Buying Requirement Details
Email Id
Mobile number

Other Products in 'Active Pharmaceutical Ingredients' category